ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671095; 2) Community: the network communities that were significantly associated with the response to NSC 671095; 3) Molecule: the relationships between components within communities and NSC 671095; 4) MDR: the compounds that were significantly associated with the NSC 671095.

NSC Compound Enrichment Correlation
NSC 13275 Null 0.0478540623811426 0.22924942
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0478540623811426 0.2409294
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0478540623811426 0.073209434
NSC 15795 Null 0.0478540623811426 0.26586105
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0478540623811426 0.3481857
NSC 176323 Camptothecin Derivative 0.0478540623811426 0.17872555
NSC 330507 Tanespimycin 0.0478540623811426 0.25371152
NSC 48890 Null 0.0478540623811426 0.32245469
NSC 58574 Pyrimidine, 2,4,5-trichloro-6-propyl- 0.0478540623811426 0.10953083
NSC 626676 Null 0.0478540623811426 0.084222169
Total:66  Current:61    [First] [Prev] [Next] [Last]